PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.30%
Net income growth under 50% of ORCL's 53.56%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.28%
Both reduce yoy D&A, with ORCL at -2.60%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
232.81%
Well above ORCL's 58.70% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
10.78%
SBC growth of 10.78% while ORCL is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-297.00%
Both reduce yoy usage, with ORCL at -187.56%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-242.90%
AR is negative yoy while ORCL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.77%
Both reduce yoy usage, with ORCL at -187.56%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
92.70%
Well above ORCL's 15.38%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-48.46%
Both yoy CFO lines are negative, with ORCL at -79.56%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-49.30%
Negative yoy CapEx while ORCL is 34.62%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
66.31%
Acquisition spending well above ORCL's 38.83%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
16.79%
Purchases well above ORCL's 5.83%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
40.33%
We have some liquidation growth while ORCL is negative at -54.53%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
305.21%
We have mild expansions while ORCL is negative at -123.92%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both yoy lines negative, with ORCL at -44.94%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-138.61%
We cut yoy buybacks while ORCL is 70.40%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.